Technology & Data Science for Enhanced Patient Care

JMSACL Logo

Learning Center

Access additional learning opportunities.

EUROPE 2015

Help Us Reach Our Educational Support Goal of $40,000
Educational Travel Grants supported in part by:
 

Video Viewing Request

You are requesting to view the following presentation:

Presented at 2015_EU

Development of Clinical Assays Based on Parallel Reaction Monitoring
Bruno Domon
Luxembourg Clinical Proteomics Center

Targeted proteomics analyses of biomarker are routinely performed on triple quadrupole mass spectrometers, which present limited selectivity, due to low resolution of the mass filters. The targeted analyses of clinical samples carried out on a quadrupole-orbitrap mass spectrometer using parallel reaction monitoring (PRM) showed a significant gain in sensitivity and selectivity. A new acquisition method leveraging the presence of internal standards showed a dramatic improvement of the reliability and the precision of the analyses. The method has a broad applicability to the quantitative analysis of clinical samples, such as lung cancer plasma samples to discriminate the disease stages and subtypes; and to tissue samples to map driver mutations (EGFR and KRAS).

Please Enter the email address used to register for the most recent conference and you will be emailed a link that will allow you to view the requested video.

Email: